Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy
文献类型：期刊论文
| 刊名 | CHINESE MEDICAL JOURNAL
 |
| 出版日期 | 2014 |
| 卷号 | 127 |
| 关键词 | PREVIOUSLY TREATED PATIENTS TYROSINE KINASE INHIBITORS FACTOR RECEPTOR MUTATIONS SKIN RASH ERLOTINIB EFFICACY GEFITINIB EGFR TRIAL BENEFIT ADENOCARCINOMA non-small cell lung cancer icotinib antitumor activity adverse events |
| ISSN号 | 0366-6999 |
| 其他题名 | Efficacy and safety of icotinib in Chinese patients with advanced nonsmall cell lung cancer after failure of chemotherapy |
| 英文摘要 | Background The preclinical experiments and several clinical studies showed icotinib, an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in Chinese patients with advanced non-small cell lung cancer (NSCLC) who failed previous chemotherapy. We performed a retrospective study of the efficacy and safety of icotinib monotherapy in a different and more recent sample of Chinese patients. |
| 资助项目 | [Zhejiang Provincial Natural Science Foundation of China] ; [Development Center for Medical Science and Technology, Ministry of Health of China] |
| 语种 | 英语 |
| CSCD记录号 | CSCD:5039970 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/50996]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 推荐引用方式 GB/T 7714 | . Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy[J]. CHINESE MEDICAL JOURNAL,2014,127. |
| APA | (2014).Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy.CHINESE MEDICAL JOURNAL,127. |
| MLA | "Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy".CHINESE MEDICAL JOURNAL 127(2014). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。